2021
DOI: 10.1080/14737159.2021.1922080
|View full text |Cite
|
Sign up to set email alerts
|

Applications of the CRISPR-Cas system for infectious disease diagnostics

Abstract: Introduction: Rapid and accurate diagnostic approaches are essential for impeding the spread of infectious diseases. This review aims to summarize current progress of clustered regularly interspaced short palindromic repeats (CRISPR)-associated (Cas) systems in the applications for diagnostics of infectious diseases including the ongoing COVID-19 epidemic. Areas covered: In this review, we discuss class 2 CRISPR-Cas biosensing systems-based diagnostics in various emerging and reemerging infectious diseases, CR… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 108 publications
(112 reference statements)
0
10
0
Order By: Relevance
“…In recent years, the discovery of CRISPR-Cas system has revolutionized biology, enabling accurate editing of almost any DNA or RNA molecule ( 15 18 ). Some Cas proteins have been found to have accessory cleavage activity, such as Cas12a and Cas13a.…”
Section: Discussionmentioning
confidence: 99%
“…In recent years, the discovery of CRISPR-Cas system has revolutionized biology, enabling accurate editing of almost any DNA or RNA molecule ( 15 18 ). Some Cas proteins have been found to have accessory cleavage activity, such as Cas12a and Cas13a.…”
Section: Discussionmentioning
confidence: 99%
“…Infectious diseases pose serious threats on public health, causing 17 million deaths every year (Khan et al 2022 ). The mortality of infectious diseases account for 15% of global deaths (Li et al 2021 ). COVID-19 is a global pandemic that has placed enormous burdens on medical resources and social welfare.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, for the highly sensitive detection of Escherichia coli O157:H7, the RPA–CRISPR/Cas12 system was developed [ 20 ], and LAMP–CRISPR/Cas [ 21 ]; for Salmonella spp.–RPA–CRISPR/Cas13 [ 22 ] and for Campylobacter jejuni –RPA–CRISPR/Cas12a [ 23 ]. Thus, biosensor systems based on isothermal amplifications and CRISPR/Cas are promising candidates for ultrasensitive detection of bacterial pathogens, which is confirmed by several review articles [ 24 , 25 ], and for the development of non-laboratory biosensor systems based on them [ 26 , 27 ].…”
Section: Introductionmentioning
confidence: 87%